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Summary: This paper presents the results of a joint European external quality control survey for thyrotropin
determinations in blood dried on filter paper, carried out in 1986 in cooperation with several national quality
control organizations. For the evaluation, 124 participants presented their individual diagnostic classifications
in addition to their analytical results. Although, in relation to earlier studies of this kind, there was a significant
improvement in interlaboratory precision the results still showed variance which depended on the analytical
method and, possibly on the country in which it was performed. Regional differences were also evident in
the diagnostic classifications.
Introduction
On the 5th. and 6th. December, 1984, a Symposium
was held in Lilie, France on the subject of "Neonatal
Screening and Quality Control". One of the results
of the Symposium was a plan to carry out annually a
joint European quality control survey pf screening
analyses for hypothyroidism and phenylketonuria.
The first joint Eürppeän external quality control sur-
vey of thyrotropin determinations was conducted by
the French Organisation for external quality assess-
ment in December 1985, the second by the "Deutsche
Gesellschaft für Klinische Chemie" in June 1986. The
ÜK External Quality Assessment Scheine for Thy-
roid-related Hormones is riow preparing a third one
for September 1987.
The present paper reports on the results of the second
joint European quality control survey.
Materials and Methods
Control specimens
As samples, the participants each received 4 cards of filter paper
(Schleicher & Schüll 2992) with 3 drops of dried blood each.
The desired thyrotropin concentrations were attained by adding
the Ist reference preparation 1974 (68/38) to whole blppd con-
taining low thyrotropin concentrations (haematocrit-corrected).
This resulted in the following concentrations, which were also
taken äs target values for the evaluation of the individual
results:
Sample l 13 mU/1
Sample 2 7 mU/1
Sample 3 25 mU/1
Sample 4 37 mU/1
Quality control survey
Four different samples each were sent to 153 laboratories in
the following countries:
France 25
Great Britain 30
Italy 24
Spain 16
Federal Republic 31
pf Germany
Others 27
(including one laboratory in Por-
tugal)
(Laboratories of 14 other coun-
tries that ordinarily participate
directly in the collaborative sur-
veys of the Deutsche Gesellschaft
für Klinische Chemie)
The analyses were carried out from June 9 to 21, 1986.
Documentation of the results and findings
Together with control samples, the participants in the quality
control surveys received a registration form. The results of two
single determinations and their mean in mU per l of blood were
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entered on these forms. In addition, a diagnostic classification
of the analysis result was required:
1) normal
2) a case of congenital hypothyroidism possibly or
3) probably pathologic.
Further, when a commerciaily available test kit had been used
for the determinations, the name of the kit producer was re-
quested.
Evaluation
After the results had been collected, evaluation was then begun
with the help of electronic data processing. The mean of the
individual estimations for each double determination was data
processed äs the analysis result.
Changes made after the first evaluation of the survey had been
sent out to the participants:
Four participants had cited the thyrotropin concentration in
serum instead of in blood, äs was indicated in the experiment
instructions. As a result of Information handed in at a later
date, the readings from these participants were halved for this
present evaluation. Moreover, now included are four additional
participants whose results had arrived too late for initial eval-
uation.
In order to detect pössible correlations, the results were divided
into 2 sub-groups:
1) Those that had worked with the same commercial kits and
2) those from the same country (excepting a small number of
laboratories from countries in the subgroup "others")
The median of the values served to establish the location pa-
rameter of the collective values, and the distance between the
25%-75% and the 16%-84% percentiles, respectively, served
to describe the dispersion.
Results and Discussion
124 laboratories sent in their analysis results for eval-
uation. The analysis methods applied are based on
the analytic pfinciples for determining thyrotropin in
dried blood that were developed in the seventies (l,
2). According to the particulars given by the partici-
pants, 21 of them üsed modifications they had devel-
oped themselves, 88 carried out the analysis with test
kits from 12 different and named manufacturers,
while 15 used other kits ör gave no data (tab. 1).
In agreement with earlier studies (3, 4), there were
again no essentiäl differences between the tatget val-
ues and the medians of all the results (tab. 2). Inter-
laboratory precision, however, had significantly im-
proved, äs can be seen by comparing the relative
deviatioiis of 16% and of 84% percentiles with the
corresponding values from past external quality con-
trol surveys. This trend toward greater precision, al-
ready apparent äs early äs 1983, therefore continues
for these semi-quantitative deternuiiaticms (5).
An important reason föf this improvement seems to
be that the differences in results now depend less on
which kit is used (6). If one takes for comparison the
medians of results obtained but at least 3 participants
with the same commercial kit, then for a speciinen
with 31 mU/1 thyrotropin in 1982 (3) the greatest,
relative negative deviation of a kit median from the
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Fig. 1. Medians of results from at least six laboratories using the same commercial kits for 4 diflferent thyrotropin specimens.
The numbers in the figure are the code numbers according to table 1. For speeimen 3 the medians of the kits No. 32 (3
laboratories) and No. 44 (4 laboratories) are given additionally(see text).
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Tab. 1. Number of participating laboratories from different countries using different kits.
Commercial Kits
Becton-Dickinson
Behring
CIS/CEA
Mallinckrodt
Corning
Diagnostic Products
Henning
IRE
LKB
Pharmacia
Röche
Serono/Biodata
Other
Own methods
Code No. France
18
20
30 18
32
40
44
48
53
63
72
74
76
98 3
99
F. R.
Germany
7
1
1
1
1
6
6
1
1
Great
Britain
1
6
3
4
4
11
Italy
3
2
1
5
1
1
Spain
Portugal
2
2
1
5
2
Other
countries
3
1
1
7
4
1
2
5
Tab. 2. Target values, medians (M), 16% and 84% percentiles äs well äs their relative deviations from the medians of the joint
European thyrotropin survey 1986. For comparison the mean relative deviations calculated from 7 surveys in 1980 —
1982 are shown for the given concentrations (3).
Sample Target
value
(mU/1)
1
2
3
4
13
7
25
37
Mediän
(mU/1)
12.1
7.99
23.8
36.5
Percentiles (mU/1)
16% 84%
8.74
5.11
18.2
29.0
16.6
12.0
29.5
44.0
Relative deviations of percentiles
1986
 1980-82 (mean)
M - 16% 84% - M M - 16% 84% - M
M
-0.28
-0.36
-0.24
-0.21
M
+ 0.37
+ 0.50
+ 0.24
+ 0.21
M
-0.32
-0.42
-0.27
-0.26
M
+ 0.50
+ 0.79
+ 0.39
+ 0.39
target value was —0.32 and the greatest, relative
positive deviation + 0.35. In 1986, maximüm relative
deviations of —0.25 and + 0.25 were found for the
specimen with 25 mU/1, when — äs is necessary for
comparison with the former data — kits No. 32 (3
participants) and No. 44 (4 participants) were addi-
tionally taken into account (fig. 1).
However, a first glance still gives the impression that
the type of kits used played a leading role in the
results. Although the medians öf the results from
France agf eed very well in 3 out of 4 cases with the
target values, it is otherwise conspicuous that in
France where 18 from 21 laboratories used kit No.
30 and in Italy where 5 from 13 laboratories preferred
kit No. 76, the highest values, almost without excep-
tion, were recorded. As no comparative values for
other known kits were available for France, it is not
possible to decide whether higher values were due to
the kit or to the region. The results from Italy —-
where different kits were used — at least do not
exclude the possibility that regional factors, whatever
they may be, could have played a role. Of their 52
results, only 11 were below the medians of all the
participants; and with kit No. 18 the medians for Italy
were äs much äs 4 mU/1 (specimen 3) higher than for
the Federal Republic of Germany.
Much more homogeneous than the analysis results
were the diagnostic classifications which the partici-
pants derived from them (fig. 2). For specimens l, 2
and 4, only a few participants cited a classification —
either "normal'' or "possibly/probably pathological"
— which deviated from the majority. These few di-
vergent classifications could be due to grave, analyt-
ical errors.
It is a different case for the classification of the spec-
imen in which the thyrotropin concentration (25
mU/1) is close to the decision limit, set most frequently
at around 20 mU/1 by the laboratories (3). Here, äs
a result of unavoidable analytic dispersion, there
should have been a higher proportion of divergent
classifications. It was therefore remarkable when a
considerable number of French laboratories listed this
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Fig. 2. Survey results of thyrotropin determinations established by laboratories from different countries plus the ratio of the
diagnostic classifications that differ from the majority: "normal" and "possibly/probably pathologic" respectively.
Fig. 2 a: specimen 2; fig. 2b: specimeii 1; fig. 2c: specimen 3; fig. 2d: specimen 4.
(n = number; Min. = lowest value; Med. = median; Max. = highest value; -·— 25%, median and 75% percentile;
A location of target value. Countries: F = France; D = Federal Republic of Germany; GB = Great Britain; I = Italy;
E/P = Spain/Portugal)
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classification äs "normal", although only one of them detect cases of congenital hypothyroidism, the ques-
had found a value under 20 mU/1. The decision limit tion arises of whether a higher value should not be
is apparently allowed a higher ränge in France than agreed on in the interest of coordinating the settings
in most other countries; in the Federal Republic of for decision limits. This was suggested in 1983 by
Germany it is set at a maximum 20 mU/1. As there Wieland & v. Reuss, in order to reduce the number of
is no evidenee that French screening often fails to superfluous, data-seeking tests on patients.
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